Abstract
A series of 2,2-dimethyl-3,3-diphenyl-propanamides as novel glucocorticoid receptor modulators is reported. SAR exploration led to the identification of 4-hydroxyphenyl propanamide derivatives displaying good agonist activity in GR-mediated transrepression assays and reduced agonist activity in GR-mediated transactivation assays. Compounds 17 and 30 showed anti-inflammatory activity comparable to prednisolone in the rat carrageenan-induced paw edema model, with markedly decreased side effects with regard to increases in blood glucose and expression of hepatic tyrosine aminotransferase. A hypothetical binding mode accounting for the induction of the functional activity by a 4-hydroxyl group is proposed.
Original language | English (US) |
---|---|
Pages (from-to) | 8241-8251 |
Number of pages | 11 |
Journal | Journal of Medicinal Chemistry |
Volume | 53 |
Issue number | 23 |
DOIs | |
State | Published - Dec 9 2010 |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery